Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)
Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)
Approved
Approval ID
1c149b86-5f9d-4e60-8f17-4ec03ca80563
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 30, 2020
Manufacturers
FDA
Haemonetics Corporation
DUNS: 057827420
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CITRIC ACID MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, ANHYDROUS DEXTROSE
PRODUCT DETAILS
NDC Product Code57826-455
Application NumberBN000127
Marketing CategoryC73594
Route of AdministrationEXTRACORPOREAL
Effective DateSeptember 30, 2020
Generic NameCITRIC ACID MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, ANHYDROUS DEXTROSE
INGREDIENTS (5)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CITRIC ACID MONOHYDRATEActive
Quantity: 32.7 mg in 1 mL
Code: 2968PHW8QP
Classification: ACTIM
ANHYDROUS DEXTROSEActive
Quantity: 464 mg in 1 mL
Code: 5SL0G7R0OK
Classification: ACTIB
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEActive
Quantity: 22.2 mg in 1 mL
Code: 593YOG76RN
Classification: ACTIB
TRISODIUM CITRATE DIHYDRATEActive
Quantity: 263 mg in 1 mL
Code: B22547B95K
Classification: ACTIM